Surgalign, RTI Settle Lawsuit Over OEM Biz Sale

Surgalign Holdings has begun a global settlement agreement with Pioneer Surgical Technology d/b/a Resolve Surgical Technologies and RTI Surgical (together “RTI”), relating to sale of its OEM business in 2020 and the continued relationship the company has had with RTI since.
 
The parties have amended various agreements including distribution agreements for spinal implants and biologics.
 
All parties settled litigation and released each other from potential claims. Surgalign was released from the obligation to cure a purchase shortfall for the current year and reduced minimum annual purchase requirements. Further, the sole-source relationship was extended an additional two years with updated supply chain previsions that reflect the separation of Surgalign and Resolve/RTI.
 
“We are pleased to settle the dispute with Resolve and RTI and look forward to the future business our companies can do together,” Terry Rich, president and CEO of Surgalign told the press. “The negotiations gave us the opportunity to work through post-split issues that we identified over the past two years, following separation. The newly amended contracts are a better fit for our ongoing relationship and our current business.”
 
The companies separated in July 2020 and Resolve/RTI continues to offer Surgalign-distributed products in the U.S. and about 50 countries globally.